NCT05445713View on ClinicalTrials.gov

A Cross-sectional, Observational Study to Characterise Long COVID-19 in an Urban Sample of South African Adults

CompletedOBSERVATIONAL

Enrollment

400

Participants

Timeline

Start Date

August 10, 2022

Primary Completion Date

October 30, 2024

Study Completion Date

November 25, 2024

Conditions

Long COVID

Trial Locations (2)

2193

Sunnyside Office Park, Johannesburg

2198

Charlotte Maxeke Johannesburg Academic Hospital (CMJAH), Johannesburg

All Listed Sponsors

lead

University of Witwatersrand, South Africa

OTHER